Skip to main content
Transactions of the American Ophthalmological Society logoLink to Transactions of the American Ophthalmological Society
. 1992;90:481–504.

The ocular manifestations of sickle-cell disease: a prevalence and natural history study.

J G Clarkson 1
PMCID: PMC1298447  PMID: 1494832

Abstract

Prophylactic photocoagulation may have a role in the treatment of proliferative sickle retinopathy in selected patients with SC disease, but none of the studies reported to date have established that such treatment of these eyes improves the long-term visual outcome as compared with the natural history as documented in this study. The similar visual outcomes in the eyes reviewed in this natural history study as compared with those that have been treated with photocoagulation should not be unexpected, because there is greater predilection for spontaneous involution or autoinfarction of the neovascular tissue in SC disease as opposed to the neovascularization that develops in other retinal vascular disease. A controlled, multicenter clinical trial designed to study those eyes at greatest risk should be considered. Such a trial should specify patient age (15 to 30 years), hemoglobin type (SC disease), and a minimum threshold of active proliferative disease (60 degrees or greater). Such criteria have been suggested by others. By comparing the outcome of eligible eyes randomly assigned to treatment or observation and followed for an extended period, it will be possible to learn whether laser photocoagulation offers a better prognosis than the natural history of proliferative sickle retinopathy. There is no question that in some eyes with proliferative sickle retinopathy, nonclearing vitreous hemorrhage and/or retinal detachment will develop. Clear definition of the risk factors leading to these advanced stages, however, is lacking, and the value of treatment is uncertain.

Full text

PDF
481

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Clarkson J. G., Altman R. D. Angioid streaks. Surv Ophthalmol. 1982 Mar-Apr;26(5):235–246. doi: 10.1016/0039-6257(82)90158-8. [DOI] [PubMed] [Google Scholar]
  2. Cohen S. B., Fletcher M. E., Goldberg M. F., Jednock N. J. Diagnosis and management of ocular complications of sickle hemoglobinopathies: Part II. Ophthalmic Surg. 1986 Feb;17(2):110–contd. [PubMed] [Google Scholar]
  3. Condon P. I., Serjeant G. R. Behaviour of untreated proliferative sickle retinopathy. Br J Ophthalmol. 1980 Jun;64(6):404–411. doi: 10.1136/bjo.64.6.404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Condon P. I., Serjeant G. R. Ocular findings in homozygous sickle cell anemia in Jamaica. Am J Ophthalmol. 1972 Apr;73(4):533–543. doi: 10.1016/0002-9394(72)90005-0. [DOI] [PubMed] [Google Scholar]
  5. Condon P. I., Serjeant G. R. Photocoagulation and diathermy in the treatment of proliferative sickle retinopathy. Br J Ophthalmol. 1974 Jul;58(7):650–662. doi: 10.1136/bjo.58.7.650. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Condon P. I., Serjeant G. R. Photocoagulation in proliferative sickle retinopathy: results of a 5-year study. Br J Ophthalmol. 1980 Nov;64(11):832–840. doi: 10.1136/bjo.64.11.832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Condon P., Jampol L. M., Farber M. D., Rabb M., Serjeant G. A randomized clinical trial of feeder vessel photocoagulation of proliferative sickle cell retinopathy. II. Update and analysis of risk factors. Ophthalmology. 1984 Dec;91(12):1496–1498. doi: 10.1016/s0161-6420(84)34121-5. [DOI] [PubMed] [Google Scholar]
  8. Cruess A. F., Stephens R. F., Magargal L. E., Brown G. C. Peripheral circumferential retinal scatter photocoagulation for treatment of proliferative sickle retinopathy. Ophthalmology. 1983 Mar;90(3):272–278. doi: 10.1016/s0161-6420(83)34577-2. [DOI] [PubMed] [Google Scholar]
  9. EDINGTON G. M., SARKIES J. W. R. Two cases of sickle-cell anaemia associated with retinal microaneurysms. Trans R Soc Trop Med Hyg. 1952 Jan;46(1):59–62. doi: 10.1016/0035-9203(52)90004-7. [DOI] [PubMed] [Google Scholar]
  10. Farber M. D., Jampol L. M., Fox P., Moriarty B. J., Acheson R. W., Rabb M. F., Serjeant G. R. A randomized clinical trial of scatter photocoagulation of proliferative sickle cell retinopathy. Arch Ophthalmol. 1991 Mar;109(3):363–367. doi: 10.1001/archopht.1991.01080030065040. [DOI] [PubMed] [Google Scholar]
  11. Fox P. D., Acheson R. W., Serjeant G. R. Outcome of iatrogenic choroidal neovascularisation in sickle cell disease. Br J Ophthalmol. 1990 Jul;74(7):417–420. doi: 10.1136/bjo.74.7.417. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Goldbaum M. H., Fletcher R. C., Jampol L. M., Goldberg M. F. Cryotherapy of proliferative sickle retinopathy, II: triple freeze-thaw cycle. Br J Ophthalmol. 1979 Feb;63(2):97–101. doi: 10.1136/bjo.63.2.97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Goldberg M. F. Natural history of untreated proliferative sickle retinopathy. Arch Ophthalmol. 1971 Apr;85(4):428–437. doi: 10.1001/archopht.1971.00990050430006. [DOI] [PubMed] [Google Scholar]
  14. Goldberg M. F. Treatment of proliferative sickle retinopathy. Trans Am Acad Ophthalmol Otolaryngol. 1971 May-Jun;75(3):532–556. [PubMed] [Google Scholar]
  15. Jacobson M. S., Gagliano D. A., Cohen S. B., Rabb M. F., Jampol L. M., Farber M. D., Goldberg M. F. A randomized clinical trial of feeder vessel photocoagulation of sickle cell retinopathy. A long-term follow-up. Ophthalmology. 1991 May;98(5):581–585. doi: 10.1016/s0161-6420(91)32246-2. [DOI] [PubMed] [Google Scholar]
  16. Jampol L. M., Condon P., Farber M., Rabb M., Ford S., Serjeant G. A randomized clinical trial of feeder vessel photocoagulation of proliferative sickle cell retinopathy. I. Preliminary results. Ophthalmology. 1983 May;90(5):540–545. doi: 10.1016/s0161-6420(83)34537-1. [DOI] [PubMed] [Google Scholar]
  17. Kimmel A. S., Magargal L. E., Stephens R. F., Cruess A. F. Peripheral circumferential retinal scatter photocoagulation for the treatment of proliferative sickle retinopathy. An update. Ophthalmology. 1986 Nov;93(11):1429–1434. doi: 10.1016/s0161-6420(86)33549-8. [DOI] [PubMed] [Google Scholar]
  18. Konotey-Ahulu F. I. The sickle cell diseases. Clinical manifestations including the "sickle crisis". Arch Intern Med. 1974 Apr;133(4):611–619. [PubMed] [Google Scholar]
  19. LIEB W. A., GEERAETS W. J., GUERRY D., 3rd Sickie-cell retionapathy. Ocular and sysmetic manifestations of sicklecell disease. Acta Ophthalmol Suppl. 1959;Suppl 58:1–45. [PubMed] [Google Scholar]
  20. Lee C. B., Woolf M. B., Galinos S. O., Goldbaum M. H., Stevens T. S., Goldberg M. F. Cryotherapy of proliferative sickle retinopathy. Part I. Single freeze-thaw cycle. Ann Ophthalmol. 1975 Oct;7(10):1299–1308. [PubMed] [Google Scholar]
  21. Moriarty B. J., Acheson R. W., Condon P. I., Serjeant G. R. Patterns of visual loss in untreated sickle cell retinopathy. Eye (Lond) 1988;2(Pt 3):330–335. doi: 10.1038/eye.1988.62. [DOI] [PubMed] [Google Scholar]
  22. Nagpal K. C., Asdourian G., Goldbaum M., Apple D., Goldberg M. F. Angioid streaks and sickle haemoglobinopathies. Br J Ophthalmol. 1976 Jan;60(1):31–34. doi: 10.1136/bjo.60.1.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Nagpal K. C., Goldberg M. F., Rabb M. F. Ocular manifestations of sickle hemoglobinopathies. Surv Ophthalmol. 1977 Mar-Apr;21(5):391–411. doi: 10.1016/0039-6257(77)90042-x. [DOI] [PubMed] [Google Scholar]
  24. Nagpal K. C., Patrianakos D., Asdourian G. K., Goldberg M. F., Rabb M., Jampol L. Spontaneous regression (autoinfarction) of proliferative sickle retinopathy. Am J Ophthalmol. 1975 Nov;80(5):885–892. doi: 10.1016/0002-9394(75)90285-8. [DOI] [PubMed] [Google Scholar]
  25. Neel J. V. The Inheritance of Sickle Cell Anemia. Science. 1949 Jul 15;110(2846):64–66. doi: 10.1126/science.110.2846.64. [DOI] [PubMed] [Google Scholar]
  26. PATON D. Angiod streaks and sickle cell anemia: a report of two cases. Arch Ophthalmol. 1959 Nov;62:852–858. doi: 10.1001/archopht.1959.04220050112018. [DOI] [PubMed] [Google Scholar]
  27. PATON D. The conjunctival sign of sickle-cell disease. Arch Ophthalmol. 1961 Jul;66:90–94. doi: 10.1001/archopht.1961.00960010092020. [DOI] [PubMed] [Google Scholar]
  28. PAULING L., ITANO H. A. Sickle cell anemia a molecular disease. Science. 1949 Nov 25;110(2865):543–548. doi: 10.1126/science.110.2865.543. [DOI] [PubMed] [Google Scholar]
  29. Raichand M., Goldberg M. F., Nagpal K. C., Goldbaum M. H., Asdourian G. K. Evolution of neovascularization in sickle cell retinopathy. A prospective fluorescein angiographic study. Arch Ophthalmol. 1977 Sep;95(9):1543–1552. doi: 10.1001/archopht.1977.04450090065005. [DOI] [PubMed] [Google Scholar]
  30. Rednam K. R., Jampol L. M., Goldberg M. F. Scatter retinal photocoagulation for proliferative sickle cell retinopathy. Am J Ophthalmol. 1982 May;93(5):594–599. doi: 10.1016/s0002-9394(14)77374-x. [DOI] [PubMed] [Google Scholar]
  31. Romayanada N., Goldberg M. F., Green W. R. Histopathology of sickle cell retinopathy. Trans Am Acad Ophthalmol Otolaryngol. 1973 Sep-Oct;77(5):OP642–OP676. [PubMed] [Google Scholar]
  32. Stevens T. S., Busse B., Lee C. B., Woolf M. B., Galinos S. O., Goldberg M. F. Sickling hemoglobinopathies; macular and perimacular vascular abnormalities. Arch Ophthalmol. 1974 Dec;92(6):455–463. doi: 10.1001/archopht.1974.01010010469002. [DOI] [PubMed] [Google Scholar]
  33. Welch R. B., Goldberg M. F. Sickle-cell hemoglobin and its relation to fundus abnormality. Arch Ophthalmol. 1966 Mar;75(3):353–362. doi: 10.1001/archopht.1966.00970050355008. [DOI] [PubMed] [Google Scholar]

Articles from Transactions of the American Ophthalmological Society are provided here courtesy of American Ophthalmological Society

RESOURCES